Mangalam Drugs & OrganicsNSE:MANGALAM -0.57%51 Days Inventory is 198.85 as of Mar. 2026, which is 43% above its 10-year median of 138.94. GuruFocus rates NSE:MANGALAM with a GF Score™ of 51/100 and a GF Value™ of ₹63.03 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 919 Drug Manufacturers companies, Mangalam Drugs & Organics ranks worse than 80.41% on this metric.
The historical rank and industry rank for Mangalam Drugs & Organics's Days Inventory or its related term are showing as below:
NSE:MANGALAM'
s Days Inventory Range Over the Past 10 Years
Min: 76.23 Med: 138.94 Max: 286.17
Current: 275.1
During the past 13 years, Mangalam Drugs & Organics's highest Days Inventory was 286.17. The lowest was 76.23. And the median was 138.94.
NSE:MANGALAM's Days Inventory is ranked worse than 80.41% of 919
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs NSE:MANGALAM: 275.10
Inventory Turnover measures how fast the company turns over its inventory within a year.
Mangalam Drugs & Organics's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.46.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Mangalam Drugs & Organics's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.53.
Mangalam Drugs & Organics (NSE:MANGALAM) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Mangalam Drugs & Organics's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Mangalam Drugs & Organics's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Mangalam Drugs & Organics Days Inventory Related Terms
Mangalam Drugs & Organics Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:MANGALAM vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Mangalam Drugs & Organics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mangalam Drugs & Organics Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Mangalam Drugs & Organics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Mangalam Drugs & Organics's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mangalam Drugs & Organics (NSE:MANGALAM) has a Days Inventory of 198.85 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Mangalam Drugs & Organics and its competitors. This is 43% above median its historical median of 138.94. Over the past decade, Mangalam Drugs & Organics' Days Inventory has ranged from 76.23 to 286.17. According to the industry distribution chart, Mangalam Drugs & Organics ranks #739 out of 919 companies in the Drug Manufacturers industry, placing it in the top 80.4%.
Is Mangalam Drugs & Organics' Days Inventory too high?
Mangalam Drugs & Organics' current Days Inventory of 198.85 is 43% above median its 10-year median of 138.94. Over the past 10 years, this metric has ranged from a low of 76.23 to a high of 286.17. The Drug Manufacturers industry median Days Inventory is 164.48. Mangalam Drugs & Organics' value of 198.85 is 20.9% above this industry median. Based on the distribution chart, Mangalam Drugs & Organics ranks #739 out of 919 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Mangalam Drugs & Organics has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mangalam Drugs & Organics' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Mangalam Drugs & Organics ranks #739 out of 919 companies for Days Inventory. This places Mangalam Drugs & Organics in the lower half of its industry. The industry median Days Inventory is 164.48. Mangalam Drugs & Organics' value of 198.85 is 20.9% above this benchmark. Historically, Mangalam Drugs & Organics' own Days Inventory has ranged from 76.23 to 286.17 over the past decade. While the company's 10-year median is 138.94 vs. the industry median of 164.48, Mangalam Drugs & Organics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mangalam Drugs & Organics's current Days Inventory of 198.85 is 20.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Mangalam Drugs & Organics and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mangalam Drugs & Organics's current Days Inventory is 198.85, which is 43% above median its own 10-year median of 138.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mangalam Drugs & Organics stock overvalued right now?
Based on GuruFocus' analysis, Mangalam Drugs & Organics (NSE:MANGALAM) is currently considered Possible Value Trap. The stock's GF Value™ is ₹63.03, compared to a current price of ₹28.09 — trading 55.4% below its estimated fair value. The current Days Inventory is 198.85, which is 43% above median its 10-year median of 138.94 and 20.9% above the Drug Manufacturers industry median of 164.48. Mangalam Drugs & Organics' overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Mangalam Drugs & Organics (NSE:MANGALAM), the current Days Inventory is 198.85 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mangalam Drugs & Organics (NSE:MANGALAM) Overvalued in 2026?
Based on GuruFocus' analysis, Mangalam Drugs & Organics stock appears to be undervalued.
The current stock price of ₹28.09 is trading 55.4% below its estimated GF Value™ of ₹63.03.
GuruFocus considers Mangalam Drugs & Organics to be Possible Value Trap.
Key valuation signals for NSE:MANGALAM:
Days Inventory: 198.85 (43% above median its 10-year median of 138.94)
GF Value™: ₹63.03 vs. price of ₹28.09 (55.4% below fair value)
Industry Position: 20.9% above the Drug Manufacturers median (#739 of 919)
No single metric tells the full story. See the NSE:MANGALAM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mangalam Drugs & Organics Ltd commenced its manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates. The company is engaged in the manufacture and sale of APIs for various therapeutic segments, including anti-malaria, anti-retroviral, and anti-hypertensive. It is approved by the Bill Clinton Foundation. The company is actively producing Pyronaridine Tetraphosphate, a new API used in antimalarial treatments. The company has received prequalification from the World Health Organization (WHO) for both micronized and non-micronized forms of Pyronaridine Phosphate.
51GF Score
Get the complete analysis for NSE:MANGALAM
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MANGALAM has been successfully added to your 
